| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Savara Inc | Director | Common Stock | 22,500 | $100,125 | $4.45 | 14 Dec 2023 | Direct |
| Savara Inc | Director | Stock Option (Right to Buy) | 40,000 | 13 Dec 2022 | Direct | ||
| Arcutis Biotherapeutics, Inc. | Director | Stock Option (Right to Buy) | 13,391 | 09 Jun 2021 | Direct | ||
| Annexon, Inc. | Director | Stock Option (Right to Buy) | 10,000 | 02 Jun 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SVRA | Savara Inc | 14 Dec 2023 | 1 | $0 | 4 | Director | 15 Dec 2023, 18:10 |
| SVRA | Savara Inc | 13 Dec 2022 | 1 | $0 | 4 | Director | 15 Dec 2022, 15:13 |
| SVRA | Savara Inc | 14 Dec 2021 | 1 | $0 | 4 | Director | 15 Dec 2021, 17:30 |
| ARQT | Arcutis Biotherapeutics, Inc. | 09 Jun 2021 | 1 | $0 | 4 | Director | 11 Jun 2021, 17:30 |
| ANNX | Annexon, Inc. | 02 Jun 2021 | 1 | $0 | 4 | Director | 04 Jun 2021, 17:00 |